Is oral cancer susceptibility inherited? Report of five oral cancer families

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 1, 1996, Pages 63-67

  Ankathil, R ^a   Mathew, A ^a   Joseph, F ^a   Nair, M K ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Alcohol; Autosomal dominant inheritance; Familial aggregation; Oral cancer; Susceptibility gene; Tobacco

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; FAMILIAL CANCER; FEMALE; HUMAN; MALE; MOUTH CANCER; PRIORITY JOURNAL; TOBACCO;

EID: 0029881822     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(95)00055-0     Document Type: Article

References (25)

1. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988, 48, 3282-3287.
2. Sanghivi LD. Epidemiologie and intervention studies, screening cancer epidemiology: the Indian scene. J Cancer Res Clin Oncol 1981, 9, 1-14.
3. Field JK, Spandidos DA. Expression of oncogenes in human tumors with special reference to the head and neck region. J Oral Pathol 1987, 16, 97-107.
4. Nair MK, Sankaranarayanan R, Padmanabhan TK, Padmakumary G. Clinical profile of 2007 oral cancers in Kerala, India. Ann Dent 1988, 47, 23-26.
5. lonov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogenesis. Nature 1993, 363,558-561.
6. Legerski RJ, Li L. DNA repair capability and cancer risk. Cancer Bull 1994, 46, 228-232.
7. Goldstein AM, Blot WJ, Greenberg RS, et al. Familial risk in oral and pharyngeal cancer. Oral Oncol, Eur J Cancer 1994, 30B, 319-322.
8. Knudson AG, Jr. Hereditary cancer, oncogene and antioncogenes. Cancer Res 1985, 45, 1437-1443.
9. Li FP. Molecular epidemiology studies of cancer in families. Br J Cancer 1993, 68, 217-219.
10. Garber JE. Markers of risk for human malignancies. Haematol/ Oncol Clin N Am 1994, 8, 471-483.
11. Walker C. Animal models of cancer susceptibility. Cancer Bull 1994, 46, 200-206.
12. Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis type I gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nature Genet 1993, 3, 122-126.
13. Santiabanez-koref MF, Birch JM, Hartley AL, et al. P53 germline mutations in Li Fraumeni Syndrome. Lancet 1991,338, 1490-1491.
14. Hall JM, Lee MK, Newman B, et al. Linkage of early onset familial breast cancer to chromosome 17q21. Science 1990, 250, 1684-1689.
15. Bishop T. BRCA1, BRAC2, BRCA3. ... A myriad of breast cancer genes. Eur J Cancer 1994, 30A, 1738-1739.
16. 2 and its association with hereditary nonpolyposis colon cancer. Cell 1993, 75, 1027-1038.
17. Field JK. Oncogenes and tumour suppressor genes in squamous cell carcinoma of the head and neck. Oral Oncol, Eur J Cancer 1992, 28B, 67-76.
18. Field JK, Zoumpourlis V, Spandidos DA, Jones AS. P53 expression and mutations in squamous cell carcinoma of the head and neck. Expression correlates with the patient's use of tobacco and alcohol. Cancer Detect Prevent 1994, 18, 197-208.
19. Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S, Boicchi M. Three discrete deletions at 3P in head and neck cancer. Cancer Res 1993, 53, 5775-5779.
20. Hsu TC, Spitz MR, Schantz SP. Mutagen sensitivity : a biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1991, 1, 83-89.
21. Schantz SP, Hsu TC. Mutagen induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients. Head Neck 1989, 11, 337-342.
22. Schantz SP, Spitz MR, Hsu TC. Mutagen sensitivity in head and neck cancer patients: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 1990, 82, 1773-1775.
23. Spitz MR, Hoque A, Trizna Z, et al. Mutagen sensitivity as a risk factor for second malignant tumours following malignancies of the upper aerodigestive tract. J Natl Cancer Inst 1994, 86, 1681-1684.
24. Cloos J, Steen I, Joenje H, et al. Association between bleomycin genotoxicity and non constitutional risk factors for head and neck cancer. Cancer Lett 1993, 74, 161-165.
25. Cloos J, Braakhuis BJ, Steen I, et al. Increased mutagen sensitivity in head and neck squamous cell carcinoma patients, particularly those with multiple primary tumours. Int J Cancer 1994, 56, 816-819.